Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is -7.04% vs -20.08% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is -1.03% vs 0.24% in Mar 2024
Investments
YoY Growth in year ended Mar 2025 is 150.00% vs 0.00% in Mar 2024
Current Assets
YoY Growth in year ended Mar 2025 is 6.45% vs -1.47% in Mar 2024
Compare Balance Sheet Results of Vista Pharma.
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
12.31
16.27
-3.96
-24.34%
Share Warrants & Outstandings
Total Reserve
33.10
2.51
30.59
1,218.73%
Shareholder's Funds
45.42
18.78
26.64
141.85%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
2.38
0.00
2.38
0.00%
Secured Loans
2.38
0.00
2.38
0.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
-4.37
0.33
-4.70
-1,424.24%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.12
0.00
0.12
0.00%
Total Non-Current Liabilities
-1.87
0.33
-2.20
-666.67%
Current Liabilities
Trade Payables
5.59
30.99
-25.40
-81.96%
Other Current Liabilities
1.74
0.18
1.56
866.67%
Short Term Borrowings
5.02
0.47
4.55
968.09%
Short Term Provisions
0.01
0.21
-0.20
-95.24%
Total Current Liabilities
12.37
31.85
-19.48
-61.16%
Total Liabilities
55.92
50.96
4.96
9.73%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
27.18
11.75
15.43
131.32%
Less: Accumulated Depreciation
8.48
3.41
5.07
148.68%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
18.70
8.34
10.36
124.22%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
10.14
0.00
10.14
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.05
0.00
0.05
0.00%
Long Term Loans & Advances
2.12
0.00
2.12
0.00%
Other Non Current Assets
0.00
0.06
-0.06
-100.00%
Total Non-Current Assets
31.01
8.41
22.60
268.73%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
8.22
3.34
4.88
146.11%
Sundry Debtors
13.54
38.31
-24.77
-64.66%
Cash and Bank
0.73
0.26
0.47
180.77%
Other Current Assets
0.41
0.05
0.36
720.00%
Short Term Loans and Advances
2.00
0.59
1.41
238.98%
Total Current Assets
24.91
42.55
-17.64
-41.46%
Net Current Assets (Including Current Investments)
12.54
10.71
1.83
17.09%
Total Current Assets Excluding Current Investments
24.91
42.55
-17.64
-41.46%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
55.92
50.96
4.96
9.73%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
7.40
0.47
6.93
1,474.47%
Book Value per share (adjusted)
7.38
11.54
-4.16
-36.05%
Annual - Borrowings
Borrowings 7.40 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -7.04% vs -20.08% in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 28.84 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -1.03% vs 0.24% in Mar 2024
Annual - Investments
Investments 0.05 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 150.00% vs 0.00% in Mar 2024
Annual - Current Assets
Current Assets 24.91 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 6.45% vs -1.47% in Mar 2024






